Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Ho Jung AN
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Hyun Jeong JEON
			        		
			        		;
		        		
		        		
		        		
			        		Sang Hoon CHUN
			        		
			        		;
		        		
		        		
		        		
			        		Hyun Ae JUNG
			        		
			        		;
		        		
		        		
		        		
			        		Hee Kyung AHN
			        		
			        		;
		        		
		        		
		        		
			        		Kyung Hee LEE
			        		
			        		;
		        		
		        		
		        		
			        		Min Ho KIM
			        		
			        		;
		        		
		        		
		        		
			        		Ju Hee KIM
			        		
			        		;
		        		
		        		
		        		
			        		Jaekyung CHEON
			        		
			        		;
		        		
		        		
		        		
			        		JinShil KIM
			        		
			        		;
		        		
		        		
		        		
			        		Su Jin KOH
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Multicenter Study
 - Keywords: Physician Orders for Life-Sustaining Treatment; Terminal cancer; Feasibility
 - MeSH: Denial (Psychology); Education; Feasibility Studies; Hospice Care; Humans; Lung; Male; Prognosis; Prospective Studies; Terminally Ill; Uncertainty
 - From:Cancer Research and Treatment 2019;51(4):1632-1638
 - CountryRepublic of Korea
 - Language:English
 - Abstract: PURPOSE: Physician Orders for Life-Sustaining Treatment (POLST) form is a legal document for terminally ill patients to make medical decisions with physicians near the end-of-life. A multicenter prospective study was conducted to evaluate the feasibility of POLST administration in actual oncological practice. MATERIALS AND METHODS: Patients with terminal cancer, age ≥ 20 years, and capable of communicating were eligible. The primary endpoint was the completion rate of POLST. Data about physicians' or patients' barriers were also collected. RESULTS: From June to December 2017, 336 patients from seven hospitals were eligible. Median patient age was 66 years (range, 20 to 94 years); 52.7% were male; and 60.4% had poor performance status. Primary cancer sites were hepato-pancreato-biliary (26.2%), lung (23.2%), and gastrointestinal (19.9%). Expected survival duration was 10.6±7.3 weeks, with 41.2% receiving hospice care, 37.9% showing progression after cancer treatment, and the remaining patients were under active treatment (15.8%) or initially diagnosed with terminal cancer (5.1%). POLST forms were introduced to 60.1% of patients, and 31.3% signed the form. Physicians' barriers were reluctance of family (49.7%), lack of rapport (44.8%), patients' denial of prognosis (34.3%), lack of time (22.7%), guilty feelings (21.5%), and uncertainty about either prognosis (21.0%) or the right time to discuss POLST (16.6%). The patients' barriers were the lack of knowledge/understanding of POLST (65.1%), emotional discomfort (63.5%), difficulty in decision-making (66.7%), or denial of prognosis (14.3%). CONCLUSION: One-third of patients completed POLST forms, and various barriers were identified. To overcome such barriers, social engagement, education, and systematic support might be necessary.
 
            